EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reimagining vaccine delivery with oral tablet immunization

Sean Tucker

Vaccine Insights · 30.03.2026 · 5 (2) · 76–80

DOI: 10.18609/vac.2026.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccine Insights, online erschienen am 30.03.2026. Verfasst von Sean Tucker. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“we built an adjuvant system where a double‑stranded RNA hairpin is co‑expressed along with the protein of interest to generate a strong immune response.”Charlotte Barker, Editor, Vaccine Insights, speaks with Sean Tucker, Founder and Chief Scientific Officer, Vaxart, about the scientific and translational journey behind the company's oral tablet vaccines and the use of controlled human infection models to refine immune correlates.

Zitieren

APA

Tucker, S. (2026). Reimagining vaccine delivery with oral tablet immunization. Vaccine Insights, 5(2), 76–80. https://doi.org/10.18609/vac.2026.016

Vancouver

Tucker S. Reimagining vaccine delivery with oral tablet immunization. Vaccine Insights. 2026;5(2):76–80. doi:10.18609/vac.2026.016

BibTeX
@article{Tucker2026,
  author = {Tucker, Sean},
  title = {Reimagining vaccine delivery with oral tablet immunization},
  journal = {Vaccine Insights},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {76–80},
  doi = {10.18609/vac.2026.016}
}
Kostenlos starten →